$2.15
-0.13-5.70%
At close: -
$2.14
-0.00990-0.46%
After Hours: 7:57 PM EDT
Comments
Loading...
Esperion Therapeutics (NASDAQ:ESPR) Stock, Earnings Estimates, EPS, And Revenue
Esperion Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 25
EPS Estimate
$-0.050
Quarterly Revenue Estimate
$62.82 M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$295.45 M
Analyze the earnings history of Esperion Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Esperion Therapeutics (ESPR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $-0.15 | $-0.18 | 16.7 % |
| Jun 2024 | 2024-08-12 | $-0.05 | $-0.15 | 66.7 % |
| Mar 2024 | 2024-05-07 | $0.34 | $0.05 | 580.0 % |
| Dec 2023 | 2024-02-27 | $-0.50 | $-0.48 | -4.17 % |
Esperion Therapeutics (ESPR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $51.63M | $51.32M | 0.61 % |
| Jun 2024 | 2024-08-12 | $73.83M | $50.59M | 46.0 % |
| Mar 2024 | 2024-05-07 | $137.74M | $84.51M | 63.0 % |
| Dec 2023 | 2024-02-27 | $32.25M | $28.70M | 12.4 % |
FAQ
When is Esperion Therapeutics (NASDAQ:ESPR) reporting earnings?
Esperion Therapeutics (ESPR) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Esperion Therapeutics (NASDAQ:ESPR)?
The Actual EPS was $-0.15, which beat the estimate of $-0.18.
What were Esperion Therapeutics’s (NASDAQ:ESPR) revenues?
The Actual Revenue was $51.6M, which beat the estimate of $51.3M.
Browse earnings estimates, EPS, and revenue on all stocks.